Asset Details
Do you wish to reserve the book?
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Do you wish to request the book?
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
2013
Overview
Facilitated pyruvate transport across the mitochondrial inner membrane is a critical step in carbohydrate, amino acid, and lipid metabolism. We report that clinically relevant concentrations of thiazolidinediones (TZDs), a widely used class of insulin sensitizers, acutely and specifically inhibit mitochondrial pyruvate carrier (MPC) activity in a variety of cell types. Respiratory inhibition was overcome with methyl pyruvate, localizing the effect to facilitated pyruvate transport, and knockdown of either paralog, MPC1 or MPC2, decreased the EC ₅₀ for respiratory inhibition by TZDs. Acute MPC inhibition significantly enhanced glucose uptake in human skeletal muscle myocytes after 2 h. These data (i) report that clinically used TZDs inhibit the MPC, (ii) validate that MPC1 and MPC2 are obligatory components of facilitated pyruvate transport in mammalian cells, (iii) indicate that the acute effect of TZDs may be related to insulin sensitization, and (iv) establish mitochondrial pyruvate uptake as a potential therapeutic target for diseases rooted in metabolic dysfunction.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
/ Animals
/ Cell Respiration - drug effects
/ Glucose
/ Humans
/ Insulin
/ Membrane Potential, Mitochondrial - physiology
/ Membrane Transport Proteins - metabolism
/ Metabolic Networks and Pathways - physiology
/ Mice
/ Mitochondrial Membranes - metabolism
/ Mitochondrial Proteins - antagonists & inhibitors
/ Mitochondrial Proteins - metabolism
/ Muscle, Skeletal - metabolism
/ myocytes
/ Neurons
/ Rats
/ Reverse Transcriptase Polymerase Chain Reaction
/ Thiazolidinediones - metabolism
